Show
Sort by
-
The prognostic value of leukemic stem cells in pediatric AML
-
Evaluation of new D-dimer reagent
-
Adenosine triphosphate release assay with different concentrations of thrombin for the assessment of platelet function disorders
-
Results of a feasibility and phase II study on bortezomib (BTZ) in pediatric multiply relapsed of refractory acute lymphoblastic leukemia: complete hematological responses with a modestly intensive regimen including BTZ
-
Prognostic relevance of CD200/BTLA deletions in pediatric precursor-B cell acute lymphoblastic leukemia treated according to the EORTD-CLG 58951 protocol
-
Ofatumumab (OFA) maintenance prolongs PFS in relapsed CLL: prolong study interim analysis results
-
The first lncRNA landscape of major genetic T-ALL subsets and guilt-by-association analysis for ETP-ALL specific lncRNAs
-
ER stress in diffuse large B cell lymphoma: GRP94 is a possible biomarker in germinal center versus activated B-cell type
-
Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia
-
Delayed elemination of methotrexate by cola beverages in a pediatric acute lymphoblastic leukemia population